Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jan 23, 2024

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	30,483,592	0	-		-	Common Stock, par value $0.0001 per share
Core Scientific Inc - Ordinary Shares - New	Matt Minnis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2024	29,111,651	0	-		-	Common Stock, par value $0.0001 per share
Core Scientific Inc - Ordinary Shares - New	Feinstein Darin	Director, Ten Percent Owner		23 Jan 2024	7,719,787	7,719,787	-		-	Tranche 1 Warrants
Core Scientific Inc - Ordinary Shares - New	Minnis Matt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	7,372,351	7,372,351	-		-	Tranche 1 Warrants
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	6,433,166	6,433,166	-		-	Tranche 2 Warrants
Core Scientific Inc - Ordinary Shares - New	Minnis Matt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,143,635	6,143,635	-		-	Tranche 2 Warrants
Core Scientific Inc - Ordinary Shares - New	Todd Duchene M.	See remarks	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2024	3,700,040	0	-		-	Common Stock, par value $0.0001 per share
Core Scientific Inc - Ordinary Shares - New	Feinstein Darin	Director, Ten Percent Owner		23 Jan 2024	3,048,359	3,048,359	-		-	Common Stock, par value $0.00001 per share
Core Scientific Inc - Ordinary Shares - New	Matt Minnis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	2,911,165	2,911,165	-		-	Common Stock, par value $0.00001 per share
Core Scientific Inc - Ordinary Shares - New	Denise Sterling	Chief Financial Officer		23 Jan 2024	1,518,472	0	-		-	Common Stock, par value $0.0001 per share
Core Scientific Inc - Ordinary Shares - New	Hollingsworth Jarvis V.	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2024	1,211,956	0	-		-	Common Stock, par value $0.0001 per share
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	1,100,000	1,100,000	-		-	Stock Option (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	974,301	0	-		-	Common Stock, par value $0.0001 per share
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	853,577	3,901,936	-		-	Common Stock, par value $0.00001 per share
Pluri Inc	Yaky Yanay	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	700,000	2,460,125 (13%)	3%		0	Common Stock
Alzamend Neuro Inc Board Meeting	Ault Milton C.	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	23 Jan 2024	666,666	0	-		-	Warrants
Alzamend Neuro Inc Board Meeting	Ault Milton C.	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	23 Jan 2024	661,168	5,498	-		0	Common Stock
Rigel Pharma	Rodriguez R. Raul	Director, CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	600,000	600,000	-		-	Employee Stock Option (Right to Buy)
InspireMD Inc	Marvin Slosman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	563,499	1,852,119	-		0	Restricted Stock Units
Core Scientific Inc - Ordinary Shares - New	Duchene M. Todd	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	557,133	557,133	-		-	Tranche 1 Warrants
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Charles Bergh V.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	503,715	782,905	-		-	Class B Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Charles Bergh V.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	503,715	0	-		-	Stock Appreciation Rights
Cardio Diagnostics Holdings Inc	Meeshanthini Dogan V.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	476,256	1,433,958	-		-	Stock Options (Right to Buy)
Cardio Diagnostics Holdings Inc	Dogan Timur	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	476,256	1,433,958	-		-	Stock Options (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Duchene M. Todd	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	464,278	464,278	-		-	Tranche 2 Warrants
Edgewise Therapeutics Inc	Thompson Peter A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 11.00 per share.	23 Jan 2024	454,545	14,436,497	-	11	4,999,995	Common Stock
Arcus Biosciences Inc	Rosen Terry	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	405,900	405,900	-		-	Stock Option (right to buy)
Core Scientific Inc - Ordinary Shares - New	Youngblood C. Kneeland	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2024	400,038	0	-		-	Common Stock, par value $0.0001 per share
Rigel Pharma	R. Raul Rodriguez	Director, CEO, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	400,000	2,089,523 (1%)	0%		0	Common Stock
Devon Energy	E. Muncrief Richard	Director, President and CEO		23 Jan 2024	378,991	2,060,259 (0%)	0%		0	Common Stock
Core Scientific Inc - Ordinary Shares - New	M. Todd Duchene	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	370,004	370,004	-		-	Common Stock, par value $0.00001 per share
Pluri Inc	Franco-Yehuda Chen	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	355,000	472,716 (2%)	1%		0	Common Stock
Core Scientific Inc - Ordinary Shares - New	Matt Minnis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	341,429	3,252,594	-		-	Common Stock, par value $0.00001 per share
Rezolute Inc	Elam Charles Nevan	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	340,000	340,000	-		-	Employee Stock Options (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	319,894	0	-		-	Common Stock, par value $0.0001 per share
Cogent Biosciences Inc	Jessica Sachs	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	300,000	300,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	John Robinson Edward	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	300,000	300,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Green L. John	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	300,000	300,000	-		-	Stock Option (Right to Buy)
Rezolute Inc	Evans Daron	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	275,000	275,000	-		-	Employee Stock Option (Right to Buy)
Pliant Therapeutics Inc	Bernard Coulie	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	256,300	256,300	-		-	Stock Option (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Hollingsworth Jarvis V.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	256,267	256,267	-		-	Tranche 1 Warrants
Cogent Biosciences Inc	Evan Kearns	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	255,000	255,000	-		-	Stock Option (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	246,736	246,736	-		-	Tranche 1 Warrants
CalciMedica Inc Board Meeting	A. Fred Middleton	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	23 Jan 2024	243,356	946,744	-	3.7	900,904	Common Stock
InspireMD Inc	Craig Shore	CFO and CAO		23 Jan 2024	238,625	879,844 (24%)	6%		0	Common Stock
InspireMD Inc	T. Gleason Shane	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	238,625	514,365 (14%)	6%		0	Common Stock
InspireMD Inc	Andrea Tommasoli	Chief Operating Officer		23 Jan 2024	238,625	495,078 (13%)	6%		0	Common Stock
Cardio Diagnostics Holdings Inc	Dogan Timur	Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	238,128	435,467	-		-	Stock Options (Right to Buy)
Cardio Diagnostics Holdings Inc	Abdullahi Khullani	VP of Revenue and Strategy		23 Jan 2024	238,128	304,128	-		-	Stock Options (Right to Buy)
Cardio Diagnostics Holdings Inc	Meeshanthini Dogan V.	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	238,128	435,467	-		-	Stock Options (Right to Buy)
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Charles V. Bergh	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2024	220,676	562,229	-		-	Class B Common Stock
InspireMD Inc	Marvin Slosman	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	215,405	682,811	-		-	Options to purchase common stock (right to buy)
Core Scientific Inc - Ordinary Shares - New	Jarvis V. Hollingsworth	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	213,556	213,556	-		-	Tranche 2 Warrants
Rigel Pharma	J. Raymond Furey	EVP, GC, CCO & Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	209,000	214,000 (0%)	0%		0	Common Stock
Rigel Pharma	Dean Schorno	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	209,000	415,519 (0%)	0%		0	Common Stock
Rigel Pharma	A. David Santos	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	209,000	363,612 (0%)	0%		0	Common Stock
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	205,614	205,614	-		-	Tranche 2 Warrants
CalciMedica Inc Board Meeting	A. Middleton Fred	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	23 Jan 2024	194,472	435,148	-	3.7	719,935	Common Stock
Cardlytics Inc	Gupta Amit	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	175,000	175,000 (0%)	0%		0	Common Stock
Cardlytics Inc	Gupta Amit	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	175,000	175,000	-		-	Restricted Stock Unit
KB Home	Mezger Jeffrey T.	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 59.40 per share.	23 Jan 2024	165,307	1,491,298 (1%)	0%	59.4	9,819,236	Common Stock
KB Home	T. Jeffrey Mezger	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.92 per share.	23 Jan 2024	165,307	1,656,605 (1%)	0%	14.9	2,466,380	Common Stock
KB Home	T. Mezger Jeffrey	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	165,307	79,406	-		-	Non-Qualified Stock Option (Right to Buy)
Devon Energy	Clay Gaspar M.	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	164,591	641,623 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Carlos Juan Jaen	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	162,400	162,400	-		-	Stock Option (right to buy)
Arcus Biosciences Inc	Jennifer Ann Jarrett	Director, Chief Operating Officer		23 Jan 2024	162,400	162,400	-		-	Stock Option (right to buy)
Micron Tech	Sanjay Mehrotra	Director, CEO and President	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	161,306	803,557 (0%)	0%		0	Common Stock
Micron Tech	Sanjay Mehrotra	Director, CEO and President	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	161,306	371,629 (0%)	0%		0	Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	V. Charles Bergh	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	160,186	2,115,711 (3%)	0%		0	Class A Common Stock
Rigel Pharma	Furey Raymond J.	EVP, GC, CCO & Corp Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	157,000	157,000	-		-	Employee Stock Option (Right to Buy)
Rigel Pharma	Dean Schorno	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	157,000	157,000	-		-	Employee Stock Option (Right to Buy)
Rigel Pharma	David Santos A.	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	157,000	157,000	-		-	Employee Stock Option (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Denise Sterling	Chief Financial Officer		23 Jan 2024	151,847	151,847	-		-	Common Stock, par value $0.00001 per share
Mirum Pharma Inc	Peetz Christopher	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	150,000	150,000	-		-	Stock Option (right to buy)
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	23 Jan 2024	144,676	727,433	-	3.7	535,591	Common Stock
Cardio Diagnostics Holdings Inc	Robert Philibert	Director, Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	142,876	805,465	-		-	Stock Options (Right to Buy)
Wells Fargo	Charles W. Scharf	Director, CEO & President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	141,618	141,618	-		-	Restricted Share Right
Rezolute Inc	Brian Roberts Kenneth	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	130,000	130,000	-		-	Employee Stock Option (Right to Buy)
Pliant Therapeutics Inc	Bernard Coulie	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	128,150	444,532	-		0	Common Stock
Core Scientific Inc - Ordinary Shares - New	Sterling Denise	Chief Financial Officer		23 Jan 2024	123,696	123,696	-		-	Tranche 1 Warrants
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	121,678	121,678	-		-	Warrant
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	121,678	121,678	-		-	Warrant
Core Scientific Inc - Ordinary Shares - New	V. Hollingsworth Jarvis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	121,196	121,196	-		-	Common Stock, par value $0.00001 per share
Arcus Biosciences Inc	SA Dimitry Nuyten	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	113,700	113,700	-		-	Stock Option (right to buy)
EyePoint Pharma Inc	S. Lurker Nancy	Director, Executive Vice Chair	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	112,700	112,700	-		-	Stock Option (Right to Buy)
EyePoint Pharma Inc	S. Lurker Nancy	Director, Executive Vice Chair	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	112,700	338,100	-		-	Stock Option (Right to Buy)
Pliant Therapeutics Inc	Cummings Keith	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	110,500	110,500	-		-	Stock Option (Right to Buy)
Devon Energy	L. Ritenour Jeffrey	EVP & CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	108,283	449,130 (0%)	0%		0	Common Stock
Devon Energy	David Harris G.	EVP Chief Corp Develop Officer		23 Jan 2024	108,283	347,514 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Tang Carolyn C.	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	108,200	108,200	-		-	Stock Option (right to buy)
Core Scientific Inc - Ordinary Shares - New	Sterling Denise	Chief Financial Officer		23 Jan 2024	103,080	103,080	-		-	Tranche 2 Warrants
Arcus Biosciences Inc	Terry Rosen	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	100,000	3,966,974 (8%)	0%		0	Common Stock
Core Scientific Inc - Ordinary Shares - New	Feinstein Darin	Director, Ten Percent Owner		23 Jan 2024	97,430	97,430	-		-	Common Stock, par value $0.00001 per share
CalciMedica Inc Board Meeting	Middleton Fred A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	97,236	97,236	-		-	Warrant
CalciMedica Inc Board Meeting	A. Fred Middleton	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	97,236	97,236	-		-	Warrant
Hartford Insurance Results Board Meeting	J. Swift Christopher	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 86.65 per share.	23 Jan 2024	94,807	170,180 (0%)	0%	86.6	8,214,714	Common Stock
Hartford Insurance Results Board Meeting	Christopher J. Swift	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	94,807	0	-		-	Stock Option
Hartford Insurance Results Board Meeting	Christopher J. Swift	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.25 per share.	23 Jan 2024	94,807	264,987 (0%)	0%	41.3	3,910,789	Common Stock
Wells Fargo	G. Jonathan Weiss	Sr. Executive Vice President		23 Jan 2024	92,960	92,960	-		-	Restricted Share Right
InspireMD Inc	Shane T. Gleason	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	91,218	183,128	-		-	Options to purchase common stock (right to buy)
InspireMD Inc	Andrea Tommasoli	Chief Operating Officer		23 Jan 2024	91,218	176,699	-		-	Options to purchase common stock (right to buy)
InspireMD Inc	Craig Shore	CFO and CAO		23 Jan 2024	91,218	311,488	-		-	Options to purchase common stock (right to buy)
CalciMedica Inc Board Meeting	A. Leheny Rachel	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 4.27 per share.	23 Jan 2024	91,086	109,926	-	4.3	388,618	Common Stock
Edgewise Therapeutics Inc	Carruthers Michael R.	Chief Financial Officer		23 Jan 2024	90,000	137,058	-		-	Stock Option (Right to Buy)
Edgewise Therapeutics Inc	R. Michael Carruthers	Chief Financial Officer		23 Jan 2024	90,000	119,024	-	1.9	173,700	Common Stock
Edgewise Therapeutics Inc	Michael R. Carruthers	Chief Financial Officer		23 Jan 2024	90,000	29,024	-	15.8	1,419,759	Common Stock
Arcus Biosciences Inc	Goeltz Robert C.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	86,600	86,600	-		-	Stock Option (right to buy)
Pliant Therapeutics Inc	Lefebvre Eric	Chief Medical Officer		23 Jan 2024	85,800	85,800	-		-	Stock Option (Right to Buy)
InspireMD Inc	Patrick Verta	EVP Clinical/Medical Affairs		23 Jan 2024	85,720	228,460 (6%)	2%		0	Common Stock
Astrana Health Inc	Dinesh Kumar	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	85,130	85,130 (0%)	0%		0	Common Stock
Samsara Inc (Class A) Board Meeting	Biswas Sanjit	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 32.40 per share.	23 Jan 2024	83,469	766,866	-	32.4	2,704,755	Class A Common Stock
Novavax Inc	John C. Jacobs	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	83,197	83,197 (0%)	0%		-	Common Stock
Novavax Inc	C. Jacobs John	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	83,197	166,393	-		-	Restricted Stock Units
Samsara Inc (Class A) Board Meeting	Bicket John	Director, See remarks, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 32.40 per share.	23 Jan 2024	82,797	761,375	-	32.4	2,682,557	Class A Common Stock
Disc Medicine Inc	Bitterman Kevin	Director	Sale of securities on an exchange or to another person at price $ 67.65 per share.	23 Jan 2024	82,500	703,660	-	67.7	5,581,125	Common Stock
KB Home	Jeff Kaminski J.	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.92 per share.	23 Jan 2024	82,082	130,256 (0%)	0%	14.9	1,224,663	Common Stock
KB Home	J. Jeff Kaminski	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	82,082	32,918	-		-	Non-Qualified Stock Option (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	81,011	81,011	-		-	Tranche 1 Warrants
Airbnb	Brian Chesky	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 141.36 per share.	23 Jan 2024	80,143	14,825,425	-	141.4	11,329,375	Class A Common Stock
Wells Fargo	Michael Santomassimo P.	Sr. EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	79,093	79,093	-		-	Restricted Share Right
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Bergh V. Charles	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.75 per share.	23 Jan 2024	76,731	2,038,980 (3%)	0%	15.7	1,208,513	Class A Common Stock
Cardlytics Inc	Gupta Amit	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 6.10 per share.	23 Jan 2024	72,658	102,342 (0%)	0%	6.1	443,286	Common Stock
CalciMedica Inc Board Meeting	Fred A. Middleton	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	72,338	72,338	-		-	Warrant
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	72,338	72,338	-		-	Warrant
Mirum Pharma Inc	Radovich Peter	PRESIDENT AND COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	70,000	70,000	-		-	Stock Option (right to buy)
Velocity Fin Inc	D. Farrar Christopher	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	69,514	611,063 (3%)	0%	15.9	1,102,492	Common Stock
Velocity Fin Inc	Farrar D. Christopher	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	69,514	680,577	-	15.9	1,102,492	Performance Stock Units
CalciMedica Inc Board Meeting	Wilson N. Robert	Director	Grant, award, or other acquisition of securities at price $ 4.27 per share.	23 Jan 2024	68,314	250,475	-	4.3	291,462	Common Stock
Wells Fargo	Powell E. Scott	SEVP & Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	67,603	67,603	-		-	Restricted Share Right
Core Scientific Inc - Ordinary Shares - New	Feinstein Darin	Director, Ten Percent Owner		23 Jan 2024	67,509	67,509	-		-	Tranche 2 Warrants
Wells Fargo	M Daley William	Vice Chairman - Public Affairs		23 Jan 2024	67,336	67,336	-		-	Restricted Share Right
Devon Energy	Cameron C. Dennis	EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	64,970	266,793 (0%)	0%		0	Common Stock
Bentley Systems Inc (Class B)	S. Bentley Gregory	Director, Chairman, CEO & President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 50.81 per share.	23 Jan 2024	64,787	7,575,504	-	50.8	3,291,827	Class B Common Stock
Pliant Therapeutics Inc	P. Hans Hull	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	63,000	63,000	-		-	Stock Option (Right to Buy)
Pliant Therapeutics Inc	Ouimette Mike	General Counsel & Corp. Secy		23 Jan 2024	63,000	63,000	-		-	Stock Option (Right to Buy)
RCM Technologies Inc	Vizi Bradley S.	Director, Executive Chairman & President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	62,500	1,546,015 (11%)	0%		0	Common Stock
Wells Fargo	R. Patterson Ellen	Sr. EVP and General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	61,457	61,457	-		-	Restricted Share Right
Wells Fargo	A. Derek Flowers	Sr. EVP and Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	60,745	60,745	-		-	Restricted Share Right
Wells Fargo	Sommers Barry	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	60,549	60,549	-		-	Restricted Share Right
KB Home	Jeffrey Mezger T.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.92 per share.	23 Jan 2024	59,157	1,550,455 (1%)	0%	14.9	882,622	Common Stock
KB Home	Mezger T. Jeffrey	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	59,157	273,843	-		-	Non-Qualified Stock Option (Right to Buy)
Pliant Therapeutics Inc	Keith Cummings	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	55,250	249,855	-		0	Common Stock
Wells Fargo	Santos Kleber	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	55,116	55,116	-		-	Restricted Share Right
Wells Fargo	Van Beurden Saul	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	54,120	54,120	-		-	Restricted Share Right
Pliant Therapeutics Inc	Cheung Lily	Chief Human Resource Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	52,000	52,000	-		-	Stock Option (Right to Buy)
Core Scientific Inc - Ordinary Shares - New	Duchene Todd M.	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	51,347	421,351	-		-	Common Stock, par value $0.00001 per share
CalciMedica Inc Board Meeting	Fred A. Middleton	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	23 Jan 2024	51,032	114,260	-	3.7	188,920	Common Stock
Core Scientific Inc - Ordinary Shares - New	Youngblood C. Kneeland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	50,654	50,654	-		-	Tranche 1 Warrants
Devon Energy	K. Cashion Tana	EVP Human Resources and Admin		23 Jan 2024	47,645	136,708 (0%)	0%		0	Common Stock
Airbnb	Brian Chesky	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 142.31 per share.	23 Jan 2024	46,736	14,778,689	-	142.3	6,650,823	Class A Common Stock
CalciMedica Inc Board Meeting	Rachel Leheny A.	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	45,543	45,543	-		-	Warrant
CalciMedica Inc Board Meeting	Leheny Rachel A.	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	45,543	45,543	-		-	Warrant
Wells Fargo	Ather Williams	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	44,481	44,481	-		-	Restricted Share Right
CBRE (Class A)	John Durburg E.	CEO, Advisory Services	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	44,213	275,771 (0%)	0%		0	Class A Common Stock
CBRE (Class A)	Queenan Daniel G.	CEO, Real Estate Investments	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	44,213	244,824 (0%)	0%		0	Class A Common Stock
Pluri Inc	Zami Aberman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	44,100	1,536,073 (8%)	0%		0	Common Stock
Scotts Miracle-Gro Co (Class A)	James Hagedorn	Director, Chairman, CEO and President, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	43,759	89,250 (0%)	0%		0	Common Shares
InspireMD Inc	S. Paul Stuka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	43,548	311,548 (8%)	1%		0	Common Stock
OFG Bancorp 10-year high	Rafael Fernandez Jose	Director, CEO & Vice Chairperson BOD	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	43,275	421,262 (0%)	0%		-	Common Stock
KB Home	J. Kaminski Jeff	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 59.50 per share.	23 Jan 2024	43,197	87,059 (0%)	0%	59.5	2,570,222	Common Stock
W. P. Carey Inc	Fox Jason E.	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	43,037	838,609 (0%)	0%		0	Common Stock
Pliant Therapeutics Inc	Eric Lefebvre	Chief Medical Officer		23 Jan 2024	42,900	199,820	-		0	Common Stock
Core Scientific Inc - Ordinary Shares - New	Youngblood C. Kneeland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	42,212	42,212	-		-	Tranche 2 Warrants
Novavax Inc	John C. Jacobs	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.26 per share.	23 Jan 2024	40,093	43,104 (0%)	0%	4.3	170,796	Common Stock
Core Scientific Inc - Ordinary Shares - New	Youngblood C. Kneeland	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	40,004	40,004	-		-	Common Stock, par value $0.00001 per share
Arcus Biosciences Inc	Jennifer Ann Jarrett	Director, Chief Operating Officer		23 Jan 2024	40,000	298,878 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Juan Jaen Carlos	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	40,000	341,475 (0%)	0%		0	Common Stock
Pluri Inc	Birger Doron	Director		23 Jan 2024	39,900	59,900 (0%)	0%		0	Common Stock
KB Home	J. Jeff Kaminski	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 59.46 per share.	23 Jan 2024	39,863	84,659 (0%)	0%	59.5	2,370,254	Common Stock
Pluri Inc	Shemesh-Rasmussen Maital	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	38,150	58,150 (0%)	0%		0	Common Stock
Mirum Pharma Inc	Peetz Christopher	Director, CHIEF EXECUTIVE OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	37,500	37,500	-		-	Restricted Stock Units
Pluri Inc	Rami Levi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	37,100	57,100 (0%)	0%		0	Common Stock
Wells Fargo	Bei Ling	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	36,874	36,874	-		-	Restricted Share Right
Pluri Inc	Abony Kenneth Lorne	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	36,750	36,750 (0%)	0%		0	Common Stock
Cardio Diagnostics Holdings Inc	Warren Hosseinion	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	35,719	502,195	-		-	Stock Options (Right to Buy)
Cardio Diagnostics Holdings Inc	Luqman Elisa	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	35,719	264,832	-		-	Stock Options (Right to Buy)
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Singh Harmit J.	EVP & Chief Fin. & Growth Ofc.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	35,596	801,154 (1%)	0%		0	Class A Common Stock
Symbotic Inc (Class A)	Boyd M. William	Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	35,297	70,607	-		-	Restricted Stock Units
Symbotic Inc (Class A)	Boyd William M.	Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	35,297	36,490	-		-	Class A Common Stock
Symbotic Inc (Class A)	M. William Boyd	Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	34,908	34,908	-		-	Restricted Stock Units
CalciMedica Inc Board Meeting	Robert Wilson N.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	34,157	34,157	-		-	Warrant
CalciMedica Inc Board Meeting	N. Wilson Robert	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	34,157	34,157	-		-	Warrant
Wells Fargo	S. Muneera Carr	EVP, CAO & Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	33,083	33,083	-		-	Restricted Share Right
Minerals Tech Inc Results Board Meeting	Dietrich T. Douglas	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	33,049	95,216	-		-	Deferred Restricted Stock Units (DRSUs)
Wells Fargo	G. Hranicky Kyle	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	33,027	33,027	-		-	Restricted Share Right
InspireMD Inc	Patrick Verta	EVP Clinical/Medical Affairs		23 Jan 2024	32,768	79,348	-		-	Options to purchase common stock (right to buy)
Mirum Pharma Inc	H. Bjerkholt Eric	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	32,000	32,000	-		-	Stock Option (right to buy)
Mirum Pharma Inc	Lara Longpre	CHIEF DEVELOPMENT OFFICER		23 Jan 2024	32,000	32,000	-		-	Stock Option (right to buy)
Mirum Pharma Inc	Vig Pamela	CHIEF SCIENTIFIC OFFICER		23 Jan 2024	32,000	32,000	-		-	Stock Option (right to buy)
Core Scientific Inc - Ordinary Shares - New	Darin Feinstein	Director, Ten Percent Owner		23 Jan 2024	31,989	31,989	-		-	Common Stock, par value $0.00001 per share
KB Home	T. Mezger Jeffrey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 60.52 per share.	23 Jan 2024	31,938	1,499,404 (1%)	0%	60.5	1,932,888	Common Stock
Pliant Therapeutics Inc	Mike Ouimette	General Counsel & Corp. Secy		23 Jan 2024	31,500	86,746	-		0	Common Stock
Pliant Therapeutics Inc	Hans Hull P.	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	31,500	216,569	-		0	Common Stock
CBRE (Class A)	Dhandapani Chandra	CEO, GWS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	30,365	152,453 (0%)	0%		0	Class A Common Stock
Rezolute Inc	Fauchet Philippe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	30,000	30,000	-		-	Director Stock Option (Right to Buy)
Rezolute Inc	Wladimir Hogenhuis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	30,000	30,000	-		-	Director Stock Option (Right to Buy)
Rezolute Inc	Kreher C. Nerissa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	30,000	30,000	-		-	Director Stock Options (Right to Buy)
Rezolute Inc	M. Gil Labrucherie	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	30,000	30,000	-		-	Director Stock Option (Right to Buy)
Westamerica Bancorp	L. David Payne	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 49.50 per share.	23 Jan 2024	30,000	303,689 (1%)	0%	49.5	1,484,928	Common Stock
EyePoint Pharma Inc	Nancy S. Lurker	Director, Executive Vice Chair	Sale of securities on an exchange or to another person at price $ 24.98 per share.	23 Jan 2024	29,956	135,441 (0%)	0%	25.0	748,250	Common Stock
KB Home	Kaminski Jeff J.	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 60.43 per share.	23 Jan 2024	29,775	54,884 (0%)	0%	60.4	1,799,303	Common Stock
Schlumberger Results Board Meeting	Khaled Mugharbel	EVP, Geographies	Sale of securities on an exchange or to another person at price $ 50.68 per share.	23 Jan 2024	29,621	357,220 (0%)	0%	50.7	1,501,192	Common Stock, $0.01 Par Value Per Share
KB Home	Jeffrey Mezger T.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.92 per share.	23 Jan 2024	29,130	1,520,428 (1%)	0%	14.9	434,620	Common Stock
KB Home	Mezger Jeffrey T.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	29,130	244,713	-		-	Non-Qualified Stock Option (Right to Buy)
InspireMD Inc	Arnold Kathryn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	29,032	215,040 (5%)	0%		0	Common Stock
InspireMD Inc	Thomas Kester J.	Director		23 Jan 2024	29,032	296,075 (8%)	0%		0	Common Stock
InspireMD Inc	Berman Michael	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	29,032	232,042 (6%)	0%		0	Common Stock
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	23 Jan 2024	28,744	30,292	-	3.7	106,410	Common Stock
Core Scientific Inc - Ordinary Shares - New	Adam Taylor Sullivan	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	28,453	28,453	-		-	Common Stock, par value $0.00001 per share
Minerals Tech Inc Results Board Meeting	Douglas T. Dietrich	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	28,382	28,382	-		-	Employee Stock Option (Right to Buy)
KB Home	J. Jeff Kaminski	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 60.45 per share.	23 Jan 2024	28,354	58,705 (0%)	0%	60.4	1,713,999	Common Stock
Arcus Biosciences Inc	Nuyten SA Dimitry	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	28,000	99,195 (0%)	0%		0	Common Stock
KB Home	Jeff J. Kaminski	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	27,990	0	-		-	Non-Qualified Stock Option (Right to Buy)
KB Home	Jeff Kaminski J.	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 59.51 per share.	23 Jan 2024	27,990	38,386 (0%)	0%	59.5	1,665,685	Common Stock
KB Home	Jeff Kaminski J.	EVP & Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.92 per share.	23 Jan 2024	27,990	66,376 (0%)	0%	14.9	417,611	Common Stock
KB Home	Jeffrey T. Mezger	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 59.36 per share.	23 Jan 2024	27,472	1,492,956 (1%)	0%	59.4	1,630,738	Common Stock
Arcus Biosciences Inc	Carolyn Tang C.	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	26,700	114,579 (0%)	0%		0	Common Stock
Travelers Companies 10-year high	Heyman H. William	Vice Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.58 per share.	23 Jan 2024	26,633	281,811 (0%)	0%	132.6	3,531,003	Common Stock
Travelers Companies 10-year high	William Heyman H.	Vice Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	26,633	15,000	-		-	Stock Options (Right to Buy)
Pliant Therapeutics Inc	Cheung Lily	Chief Human Resource Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	26,000	26,795	-		0	Common Stock
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	25,516	25,516	-		-	Warrant
CalciMedica Inc Board Meeting	Middleton A. Fred	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	25,516	25,516	-		-	Warrant
Devon Energy	D. Humphers Jeremy	SVP-Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	25,266	82,170 (0%)	0%		0	Common Stock
Four Corners Property Trust Inc	William H. Lenehan	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.09 per share.	23 Jan 2024	25,245	612,402 (0%)	0%	24.1	608,152	Common Stock
JFrog Ltd	Simon Frederic	Director	Sale of securities on an exchange or to another person at price $ 34.33 per share.	23 Jan 2024	25,000	4,909,432	-	34.3	858,220	Ordinary Shares
RCM Technologies Inc	Bradley S. Vizi	Director, Executive Chairman & President, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.99 per share.	23 Jan 2024	24,594	1,521,421 (11%)	0%	30.0	737,574	Common Stock
Airbnb	Chesky Brian	Director, CEO and Chairman, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 140.85 per share.	23 Jan 2024	24,569	14,905,568	-	140.8	3,460,492	Class A Common Stock
Wells Fargo	Kristy Fercho	Sr. Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	24,316	24,316	-		-	Restricted Share Right
Velocity Fin Inc	R. Szczepaniak Mark	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	24,205	116,530 (0%)	0%	15.9	383,891	Common Stock
Velocity Fin Inc	Szczepaniak Mark R.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	24,205	140,735	-	15.9	383,891	Performance Stock Units
OFG Bancorp 10-year high	Rafael Fernandez Jose	Director, CEO & Vice Chairperson BOD	Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.49 per share.	23 Jan 2024	22,654	398,608 (0%)	0%	36.5	826,644	Common Stock
SouthState Corp Results Board Meeting	C. Corbett John	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	22,551	101,910	-		-	Performance Share Units
Velocity Fin Inc	Taylor T. Jeffrey	Executive VP, Capital Markets	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	22,343	124,477 (0%)	0%	15.9	354,360	Common Stock
Velocity Fin Inc	Taylor T. Jeffrey	Executive VP, Capital Markets	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	22,343	146,820	-	15.9	354,360	Performance Stock Units
Wells Fargo	Kerrins Tracy	Sr. Executive Vice President		23 Jan 2024	22,045	22,045	-		-	Restricted Share Right
Arcus Biosciences Inc	Robert C. Goeltz	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	22,000	73,831 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Goeltz Robert C.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	21,300	73,131 (0%)	0%		0	Common Stock
Crown Castle Results Board Meeting	K. Daniel Schlanger	EVP & Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	21,085	21,085	-		-	Time RSUs
Shutterstock Inc	Jonathan Oringer	Director, EXECUTIVE CHAIRMAN, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 50.22 per share.	23 Jan 2024	20,383	11,022,754 (31%)	0%	50.2	1,023,634	Common Stock
Goldman Sachs	Ruemmler Kathryn H.	Chief Legal Officer, GC	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	20,074	0	-		-	Restricted Stock Units
Goldman Sachs	H. Kathryn Ruemmler	Chief Legal Officer, GC	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	20,074	24,408 (0%)	0%		-	Common Stock, par value $0.01 per share
Recursion Pharma Inc (Class A)	Blake Borgeson	Director	Sale of securities on an exchange or to another person at price $ 10.58 per share.	23 Jan 2024	20,054	7,324,364	-	10.6	212,083	Class A Common Stock
Disc Medicine Inc	Bitterman Kevin	Director	Sale of securities on an exchange or to another person at price $ 67.65 per share.	23 Jan 2024	20,000	198,326	-	67.7	1,353,000	Common Stock
Bentley Systems Inc (Class B)	Nicholas Cumins	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 50.81 per share.	23 Jan 2024	19,610	176,939	-	50.8	996,384	Class B Common Stock
Fastenal	Soderberg John Lewis	SENIOR EXECUTIVE VP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.00 per share.	23 Jan 2024	19,564	19,564 (0%)	0%	23	449,972	Common Stock
Fastenal	Soderberg Lewis John	SENIOR EXECUTIVE VP	Sale of securities on an exchange or to another person at price $ 69.02 per share.	23 Jan 2024	19,564	0 (0%)	0%	69.0	1,350,348	Common Stock
Fastenal	Lewis John Soderberg	SENIOR EXECUTIVE VP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	19,564	0	-		-	Employee Stock Option (Right to Buy)
KB Home	Jeffrey T. Mezger	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 59.59 per share.	23 Jan 2024	19,113	1,531,342 (1%)	0%	59.6	1,138,944	Common Stock
Madrigal Pharma Inc	William John Sibold	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	18,459	18,459	-		-	Stock Option (Right to Buy)
Appfolio Inc (Class A) Results Board Meeting	Goon Sien Fay	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	18,217	88,417 (0%)	0%		0	Class A Common Stock
Mirum Pharma Inc	Jolanda Howe	SVP, GLOBAL CONTROLLER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	18,000	18,000	-		-	Stock Option (right to buy)
CBRE (Class A)	E. Durburg John	CEO, Advisory Services	Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.42 per share.	23 Jan 2024	17,915	257,856 (0%)	0%	86.4	1,548,214	Class A Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	O’Neill Elizabeth	EVP & Chief Operations Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	17,798	76,022 (0%)	0%		0	Class A Common Stock
CBRE (Class A)	Queenan Daniel G.	CEO, Real Estate Investments	Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.42 per share.	23 Jan 2024	17,678	227,146 (0%)	0%	86.4	1,527,733	Class A Common Stock
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	17,648	35,304	-		-	Restricted Stock Units
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	17,648	80,272	-		-	Class A Common Stock
Mirum Pharma Inc	Peter Radovich	PRESIDENT AND COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	17,250	17,250	-		-	Restricted Stock Units
Travelers Companies 10-year high	Heyman H. William	Vice Chairman	Sale of securities on an exchange or to another person at price $ 212.51 per share.	23 Jan 2024	17,195	264,616 (0%)	0%	212.5	3,654,096	Common Stock
ENvue Medical Inc 10-year low	Cassirer Aurora	Director		23 Jan 2024	16,667	16,667	-		-	Option to Purchase Common Stock
ENvue Medical Inc 10-year low	Martin Goldstein	Director		23 Jan 2024	16,667	16,667	-		-	Option to Purchase Common Stock
ENvue Medical Inc 10-year low	Schroeder Maria	Director		23 Jan 2024	16,667	16,667	-		-	Option to Purchase Common Stock
ENvue Medical Inc 10-year low	Ferguson Michael	Director		23 Jan 2024	16,666	16,666	-		-	Option to Purchase Common Stock
ENvue Medical Inc 10-year low	Thomas R. Mika	Director		23 Jan 2024	16,666	16,666	-		-	Option to Purchase Common Stock
InspireMD Inc	Paul S. Stuka	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	16,647	105,875	-		-	Options to purchase common stock (right to buy)
Astrana Health Inc	Dinesh Kumar	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	16,316	101,446 (0%)	0%		0	Common Stock
Astrana Health Inc	Dinesh Kumar	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	16,316	117,762 (0%)	0%		0	Common Stock
Bentley Systems Inc (Class B)	Campbell Michael M	Chief Product Officer	Grant, award, or other acquisition of securities at price $ 50.81 per share.	23 Jan 2024	16,292	86,422	-	50.8	827,797	Class B Common Stock
Goldman Sachs	Philip Berlinski R.	Global Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	16,043	37,409 (0%)	0%		-	Common Stock, par value $0.01 per share
Goldman Sachs	Philip Berlinski R.	Global Treasurer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	16,043	0	-		-	Restricted Stock Units
Perdoceo Education Corporation	Nelson Todd S.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.80 per share.	23 Jan 2024	16,000	701,098 (0%)	0%	13.8	220,800	Common Stock
Perdoceo Education Corporation	Todd S. Nelson	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 18.50 per share.	23 Jan 2024	16,000	685,098 (0%)	0%	18.5	296,000	Common Stock
Perdoceo Education Corporation	Nelson Todd S.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.80 per share.	23 Jan 2024	16,000	701,098 (0%)	0%	13.8	220,800	Common Stock
Perdoceo Education Corporation	Nelson S. Todd	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	16,000	69,972	-		-	Non-Qualified Option (right to buy)
Perdoceo Education Corporation	Nelson S. Todd	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	16,000	85,972	-		-	Non-Qualified Option (right to buy)
Perdoceo Education Corporation	S. Nelson Todd	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.80 per share.	23 Jan 2024	16,000	701,098 (0%)	0%	13.8	220,800	Common Stock
Perdoceo Education Corporation	Todd Nelson S.	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	16,000	101,972	-		-	Non-Qualified Option (right to buy)
Perdoceo Education Corporation	Todd Nelson S.	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 18.50 per share.	23 Jan 2024	16,000	685,098 (0%)	0%	18.5	296,000	Common Stock
Perdoceo Education Corporation	Todd Nelson S.	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 18.50 per share.	23 Jan 2024	16,000	685,098 (0%)	0%	18.5	296,000	Common Stock
Aura Biosciences Inc	de los Pinos Elisabet	Director, See Remarks		23 Jan 2024	15,853	161,438	-	7.6	121,141	Common Stock
SouthState Corp Results Board Meeting	C. John Corbett	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	15,034	29,379	-		-	Restricted Share Units
Bentley Systems Inc (Class B)	Andre Werner	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 50.81 per share.	23 Jan 2024	15,026	255,534	-	50.8	763,471	Class B Common Stock
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	14,372	14,372	-		-	Warrant
CalciMedica Inc Board Meeting	A. Middleton Fred	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	14,372	14,372	-		-	Warrant
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	14,248	14,248	-		-	Restricted Stock Units
Bentley Systems Inc (Class B)	David Shaman R.	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 50.81 per share.	23 Jan 2024	14,236	698,435	-	50.8	723,331	Class B Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	J. Harmit Singh	EVP & Chief Fin. & Growth Ofc.	Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.75 per share.	23 Jan 2024	13,978	787,176 (1%)	0%	15.8	220,154	Class A Common Stock
CBRE (Class A)	E. Giamartino Emma	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	13,786	67,471 (0%)	0%		0	Class A Common Stock
Goldman Sachs	Coleman III P. Denis	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	13,558	48,469 (0%)	0%		-	Common Stock, par value $0.01 per share
Goldman Sachs	Denis Coleman III P.	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	13,558	0	-		-	Restricted Stock Units
Scotts Miracle-Gro Co (Class A)	Nathan Eric Baxter	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	13,472	52,597 (0%)	0%		0	Common Shares
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Tracy Layney	EVP and Chief HR Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	13,348	46,896 (0%)	0%		0	Class A Common Stock
Samsara Inc (Class A) Board Meeting	Bicket John	Director, See remarks, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 33.13 per share.	23 Jan 2024	13,203	748,172	-	33.1	437,374	Class A Common Stock
CalciMedica Inc Board Meeting	Fred Middleton A.	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	23 Jan 2024	13,184	27,609	-	3.7	48,807	Common Stock
Astrana Health Inc	Dinesh Kumar	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	13,053	130,815 (0%)	0%		0	Common Stock
Astrana Health Inc	Dinesh Kumar	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	13,053	143,868 (0%)	0%		0	Common Stock
Samsara Inc (Class A) Board Meeting	Sanjit Biswas	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 33.14 per share.	23 Jan 2024	12,531	754,335	-	33.1	415,256	Class A Common Stock
Travelers Companies 10-year high	Michael Klein Frederick	EVP & President, Personal Ins.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 140.85 per share.	23 Jan 2024	12,287	26,366 (0%)	0%	140.9	1,730,624	Common Stock
Travelers Companies 10-year high	Frederick Michael Klein	EVP & President, Personal Ins.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	12,287	10,000	-		-	Stock Options (Right to Buy)
Madrigal Pharma Inc	John William Sibold	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	12,250	62,250 (0%)	0%		0	Common Stock
Madrigal Pharma Inc	John William Sibold	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	12,250	12,250	-		-	Market Stock Unit
Symbotic Inc (Class A)	Boyd M. William	Chief Strategy Officer	Sale of securities on an exchange or to another person at price $ 41.50 per share.	23 Jan 2024	12,010	24,480	-	41.5	498,367	Class A Common Stock
Vaxcyte Inc	Grant Pickering E.	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share.	23 Jan 2024	12,000	390,814	-	1.8	21,480	Common Stock
Vaxcyte Inc	E. Grant Pickering	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	12,000	105,225	-		-	Stock Option (Right to Buy)
W. P. Carey Inc	Sanzone ToniAnn	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,988	93,867 (0%)	0%		0	Common Stock
Meta Cloud Deal	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		23 Jan 2024	11,976	1,551,336	-		-	Class B Common Stock
Meta Cloud Deal	Zuckerberg Mark	Director, COB and CEO, Ten Percent Owner		23 Jan 2024	11,976	11,976 (0%)	0%		0	Class A Common Stock
Velocity Fin Inc	Roland T. Kelly	Chief Legal Officer and GC	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	11,834	74,592 (0%)	0%	15.9	187,687	Common Stock
Velocity Fin Inc	Kelly T. Roland	Chief Legal Officer and GC	Grant, award, or other acquisition of securities at price $ 15.86 per share.	23 Jan 2024	11,834	86,426	-	15.9	187,687	Performance Stock Units
Rollins Results Board Meeting	Rollins W. Gary	Director, Chairman, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.22 per share.	23 Jan 2024	11,518	5,244,108 (1%)	0%	44.2	509,326	Common Stock, $1 Par Value
Minerals Tech Inc Results Board Meeting	D. J. Monagle	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,384	31,451	-		-	Deferred Restricted Stock Units (DRSUs)
Travelers Companies 10-year high	Michael Frederick Klein	EVP & President, Personal Ins.	Sale of securities on an exchange or to another person at price $ 210.63 per share.	23 Jan 2024	11,287	15,079 (0%)	0%	210.6	2,377,426	Common Stock
Flagstar Fin Inc Results Board Meeting	Jennifer R. Whip	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Peter Schoels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Leslie Dunn Dolin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Ronald A. Rosenfeld	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Hanif Dahya	Director, Presiding Director of Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Rosano Lawrence	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Wann Robert	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Lux Jan Marshall	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	L. Treadwell David	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Lawrence J. Savarese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	Toan Huynh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
Flagstar Fin Inc Results Board Meeting	J. Carpenter James	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,220	11,220 (0%)	0%		0	Common Stock
InspireMD Inc	Thomas Kester J.	Director		23 Jan 2024	11,098	70,111	-		-	Options to purchase common stock (right to buy)
InspireMD Inc	Arnold Kathryn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,098	70,109	-		-	Options to purchase common stock (right to buy)
InspireMD Inc	Michael Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	11,098	70,114	-		-	Options to purchase common stock (right to buy)
Bentley Systems Inc (Class B)	Ballard Brock	Chief Revenue Officer	Grant, award, or other acquisition of securities at price $ 50.81 per share.	23 Jan 2024	11,072	64,521	-	50.8	562,568	Class B Common Stock
Scotts Miracle-Gro Co (Class A)	Matthew Garth E.	EVP, CFO & Chief Admin Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	10,940	22,020 (0%)	0%		0	Common Shares
Wells Fargo	Flowers A. Derek	Sr. EVP and Chief Risk Officer	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	10,791	172,035 (0%)	0%		0	Common Stock, $1 2/3 Par Value
Wells Fargo	Derek A. Flowers	Sr. EVP and Chief Risk Officer	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	10,791	0 (0%)	0%		0	Common Stock, $1 2/3 Par Value
W. P. Carey Inc	J. Park John	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	10,759	615,135 (0%)	0%		0	Common Stock
Goldman Sachs	H. Kathryn Ruemmler	Chief Legal Officer, GC	Payment of exercise price or tax liability using portion of securities received from the company at price $ 385.96 per share.	23 Jan 2024	10,630	13,778 (0%)	0%	386.0	4,102,755	Common Stock, par value $0.01 per share
KB Home	Kaminski J. Jeff	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 61.32 per share.	23 Jan 2024	10,531	48,174 (0%)	0%	61.3	645,761	Common Stock
Remitly Global Inc	Matthew Oppenheimer	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 16.36 per share.	23 Jan 2024	10,416	4,719,685	-	16.4	170,390	Common Stock
Remitly Global Inc	Matthew Oppenheimer	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 16.27 per share.	23 Jan 2024	10,416	4,730,101	-	16.3	169,517	Common Stock
CBRE (Class A)	Dhandapani Chandra	CEO, GWS	Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.42 per share.	23 Jan 2024	10,279	142,174 (0%)	0%	86.4	888,311	Class A Common Stock
Vaxcyte Inc	E. Grant Pickering	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 63.95 per share.	23 Jan 2024	10,023	377,853	-	64.0	640,971	Common Stock
TD Synnex Corp	Urban Michael	Americas President	Sale of securities on an exchange or to another person at price $ 106.02 per share.	23 Jan 2024	10,000	25,270 (0%)	0%	106.0	1,060,200	Common Stock
TD Synnex Corp	Michael Urban	Americas President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.69 per share.	23 Jan 2024	10,000	35,270 (0%)	0%	49.7	496,900	Common Stock
TD Synnex Corp	Urban Michael	Americas President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	10,000	7,111	-		-	Employee Stock Option (Right to Buy)
JFrog Ltd	Simon Frederic	Director	Sale of securities on an exchange or to another person at price $ 34.34 per share.	23 Jan 2024	10,000	4,934,432	-	34.3	343,358	Ordinary Shares
Kymera Therapeutics Inc	W. Albers Jeffrey	Director	Sale of securities on an exchange or to another person at price $ 30.05 per share.	23 Jan 2024	10,000	0	-	30.0	300,470	Common Stock
Kymera Therapeutics Inc	Albers W. Jeffrey	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.34 per share.	23 Jan 2024	10,000	10,000	-	10.3	103,400	Common Stock
Kymera Therapeutics Inc	Albers Jeffrey W.	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	10,000	21,349	-		-	Stock Option (Right to Buy)
KB Home	Kaminski Jeff J.	EVP & Chief Financial Officer	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2024	9,788	38,386 (0%)	0%		0	Common Stock
Minerals Tech Inc Results Board Meeting	D. J. Monagle	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	9,777	9,777	-		-	Employee Stock Option (Right to Buy)
Minerals Tech Inc Results Board Meeting	Brett Argirakis	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	9,742	24,062	-		-	Deferred Restricted Stock Units (DRSUs)
Kalaris Therapeutics Inc	Diana M. Brainard	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.67 per share.	23 Jan 2024	9,500	863,742	-	0.7	6,369	Common Stock
Travelers Companies 10-year high	William Heyman H.	Vice Chairman	Sale of securities on an exchange or to another person at price $ 213.21 per share.	23 Jan 2024	9,438	255,178 (0%)	0%	213.2	2,012,297	Common Stock
Minerals Tech Inc Results Board Meeting	Jonathan Hastings J.	Senior Vice President		23 Jan 2024	9,339	26,786	-		-	Deferred Restricted Stock Units (DRSUs)
Bentley Systems Inc (Class B)	Cumins Nicholas	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.81 per share.	23 Jan 2024	9,176	167,763	-	50.8	466,233	Class B Common Stock
Corpay Inc	Lins Netto Armando	CEO Brazil	Grant, award, or other acquisition of securities at price $ 272.38 per share.	23 Jan 2024	8,982	43,870 (0%)	0%	272.4	2,446,517	Common Stock
Arcus Biosciences Inc	Azoy Alexander	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	8,850	19,070 (0%)	0%		0	Common Stock
Westamerica Bancorp	Payne David L.	Director, Chairman, President & CEO	Sale of securities on an exchange or to another person at price $ 50.95 per share.	23 Jan 2024	8,728	333,689 (1%)	0%	50.9	444,666	Common Stock
Madrigal Pharma Inc	Taub Rebecca A.	Director, Pres., R&D, and CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	8,718	8,718	-		-	Stock Option (Right to Buy)
Appfolio Inc (Class A) Results Board Meeting	Goon Fay Sien	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.55 per share.	23 Jan 2024	8,456	79,961 (0%)	0%	180.6	1,526,731	Class A Common Stock
Mueller Ind Inc Results	Hermanson Terry	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.40 per share.	23 Jan 2024	8,411	107,349 (0%)	0%	47.4	398,681	Common Stock
Minerals Tech Inc Results Board Meeting	Brett Argirakis	Group President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	8,367	8,367	-		-	Employee Stock Option (Right to Buy)
DMC Global Inc	Eric Walter	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.45 per share.	23 Jan 2024	8,362	43,533 (0%)	0%	17.5	145,917	Common Stock
W. P. Carey Inc	Sabatini M. Gino	Managing Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	8,300	573,752 (0%)	0%		0	Common Stock
KB Home	T. Mezger Jeffrey	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 61.39 per share.	23 Jan 2024	8,106	1,491,298 (1%)	0%	61.4	497,627	Common Stock
Minerals Tech Inc Results Board Meeting	Hastings Jonathan J.	Senior Vice President		23 Jan 2024	8,020	8,020	-		-	Employee Stock Option (Right to Buy)
Mueller Ind Inc Results	Terry Hermanson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	8,000	0	-		-	Stock Option (Right-to-Buy)
Mueller Ind Inc Results	Hermanson Terry	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	8,000	0	-		-	Stock Option (Right-to-Buy)
Mueller Ind Inc Results	Hermanson Terry	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.10 per share.	23 Jan 2024	8,000	99,760 (0%)	0%	23.1	184,760	Common Stock
Mueller Ind Inc Results	Hermanson Terry	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	8,000	0	-		-	Stock Option (Right-to-Buy)
Mueller Ind Inc Results	Terry Hermanson	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.58 per share.	23 Jan 2024	8,000	115,760 (0%)	0%	14.6	116,680	Common Stock
Mueller Ind Inc Results	Hermanson Terry	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.16 per share.	23 Jan 2024	8,000	107,760 (0%)	0%	12.2	97,320	Common Stock
Costco Wholesale Dividend	Craig W. Jelinek	Director	Sale of securities on an exchange or to another person at price $ 685.93 per share.	23 Jan 2024	8,000	216,211 (0%)	0%	685.9	5,487,456	Common Stock
Mirum Pharma Inc	Pamela Vig	CHIEF SCIENTIFIC OFFICER		23 Jan 2024	8,000	8,000	-		-	Restricted Stock Units
Mirum Pharma Inc	Longpre Lara	CHIEF DEVELOPMENT OFFICER		23 Jan 2024	8,000	8,000	-		-	Restricted Stock Units
Mirum Pharma Inc	Eric H. Bjerkholt	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	8,000	8,000	-		-	Restricted Stock Units
Travere Therapeutics Inc	Eric M. Dube	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 8.96 per share.	23 Jan 2024	7,873	234,722 (0%)	0%	9.0	70,542	Common Stock
SouthState Corp Results Board Meeting	Dean Young Stephen	Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	7,491	33,001	-		-	Performance Share Units
Goldman Sachs	R. Berlinski Philip	Global Treasurer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 385.96 per share.	23 Jan 2024	7,351	30,058 (0%)	0%	386.0	2,837,192	Common Stock, par value $0.01 per share
Scotts Miracle-Gro Co (Class A)	Hagedorn Chris	Division President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	7,294	66,978 (0%)	0%		0	Common Shares
Goldman Sachs	Kathryn H. Ruemmler	Chief Legal Officer, GC	Sale of securities on an exchange or to another person at price $ 379.81 per share.	23 Jan 2024	7,277	6,501 (0%)	0%	379.8	2,763,877	Common Stock, par value $0.01 per share
Madrigal Pharma Inc	Howarth Alex	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	7,238	7,238	-		-	Stock Option (Right to Buy)
Micron Tech	Sanjay Mehrotra	Director, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.20 per share.	23 Jan 2024	7,000	649,251 (0%)	0%	28.2	197,400	Common Stock
Micron Tech	Sanjay Mehrotra	Director, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	7,000	354,284	-		-	Non-qualified Stock Options
Smith Micro Software Inc	William Smith W.	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 0.77 per share.	23 Jan 2024	6,952	353,559 (0%)	0%	0.8	5,319	Common Stock
Four Corners Property Trust Inc	Morgan Gerald R.	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.09 per share.	23 Jan 2024	6,938	150,186 (0%)	0%	24.1	167,136	Common Stock
Toro Co.	Kevin N. Carpenter	VP, Global Ops & Supply Chain	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,935	6,935	-		-	Restricted Stock Units
Symbotic Inc (Class A)	Dunn Michael	See Remarks	Sale of securities on an exchange or to another person at price $ 41.50 per share.	23 Jan 2024	6,894	73,378	-	41.5	286,073	Class A Common Stock
Minerals Tech Inc Results Board Meeting	Aldag Erik	Senior Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,728	13,076	-		-	Deferred Restricted Stock Units (DRSUs)
KB Home	Kaminski Jeff J.	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 61.27 per share.	23 Jan 2024	6,710	48,174 (0%)	0%	61.3	411,122	Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Dividend	Elizabeth O’Neill	EVP & Chief Operations Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.75 per share.	23 Jan 2024	6,692	69,330 (0%)	0%	15.8	105,399	Class A Common Stock
ENvue Medical Inc 10-year low	Harold Jacob	Director, Chief Medical Officer		23 Jan 2024	6,667	6,667	-		-	Option to Purchase Common Stock
Micron Tech	Mehrotra Sanjay	Director, CEO and President	Sale of securities on an exchange or to another person at price $ 87.36 per share.	23 Jan 2024	6,665	642,586 (0%)	0%	87.4	582,254	Common Stock
Aura Biosciences Inc	B. Julie Feder	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 7.64 per share.	23 Jan 2024	6,609	62,991	-	7.6	50,521	Common Stock
CalciMedica Inc Board Meeting	A. Fred Middleton	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	6,592	6,592	-		-	Warrant
CalciMedica Inc Board Meeting	A. Fred Middleton	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jan 2024	6,592	6,592	-		-	Warrant
Astrana Health Inc	Dinesh Kumar	See remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,527	150,395 (0%)	0%		0	Common Stock
W. P. Carey Inc	Gordon G. Brooks	Managing Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,455	120,692 (0%)	0%		0	Common Stock
Teledyne Tech Results Board Meeting	Mehrabian Robert	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,431	6,431	-		-	Stock Option (right to buy)
Goldman Sachs	P. Coleman III Denis	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 385.96 per share.	23 Jan 2024	6,372	42,097 (0%)	0%	386.0	2,459,337	Common Stock, par value $0.01 per share
Pinnacle Financial Partners	A. Mccabe Robert	Director, CHAIRMAN	Sale of securities on an exchange or to another person at price $ 87.43 per share.	23 Jan 2024	6,331	202,699 (0%)	0%	87.4	553,519	PNFP Common Stock
Ingredion Inc	Seip Eric	SVP, Global Ops and CSCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2024	6,316	22,615 (0%)	0%		0	Common Stock
Teledyne Tech Results Board Meeting	Edwin Roks	Chief Executive Officer		23 Jan 2024	6,314	6,314	-		-	Stock Option (right to buy)
DraftKings Inc (Class A)	Liberman Paul	Director, See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2024	6,239	6,239	-		-	Restricted Stock Units

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jan 23, 2024

Monitor US insider transactions and discover insider buying and selling of stocks on Jan 23, 2024.

Screeners based on Insider Trading parameters